Hallek M - Search Results

1

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J, Deléage G, Hallek M. Girod A, et al. Among authors: hallek m. Nat Med. 1999 Dec;5(12):1438. doi: 10.1038/71021. Nat Med. 1999. PMID: 10581091 No abstract available.

2

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J, Deléage G, Hallek M. Girod A, et al. Among authors: hallek m. Nat Med. 1999 Sep;5(9):1052-6. doi: 10.1038/12491. Nat Med. 1999. PMID: 10470084

3

Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection.

Wobus CE, Hügle-Dörr B, Girod A, Petersen G, Hallek M, Kleinschmidt JA. Wobus CE, et al. Among authors: hallek m. J Virol. 2000 Oct;74(19):9281-93. doi: 10.1128/jvi.74.19.9281-9293.2000. J Virol. 2000. PMID: 10982375 Free PMC article.

4

Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies.

Huttner NA, Girod A, Perabo L, Edbauer D, Kleinschmidt JA, Büning H, Hallek M. Huttner NA, et al. Among authors: hallek m. Gene Ther. 2003 Dec;10(26):2139-47. doi: 10.1038/sj.gt.3302123. Gene Ther. 2003. PMID: 14625569

5

Receptor targeting of adeno-associated virus vectors.

Büning H, Ried MU, Perabo L, Gerner FM, Huttner NA, Enssle J, Hallek M. Büning H, et al. Among authors: hallek m. Gene Ther. 2003 Jul;10(14):1142-51. doi: 10.1038/sj.gt.3301976. Gene Ther. 2003. PMID: 12833123 Review.

6

Recombinant adeno-associated virus vectors.

Hallek M, Girod A, Braun-Falco M, Wendtner CM, Bogedain C, Hörer M. Hallek M, et al. IDrugs. 1998 Sep;1(5):561-73. IDrugs. 1998. PMID: 18465596

7

Real-time single-molecule imaging of the infection pathway of an adeno-associated virus.

Seisenberger G, Ried MU, Endress T, Büning H, Hallek M, Bräuchle C. Seisenberger G, et al. Among authors: hallek m. Science. 2001 Nov 30;294(5548):1929-32. doi: 10.1126/science.1064103. Science. 2001. PMID: 11729319

8

[Basis of gene therapy: principles and state of development].

Hallek M, Buening H, Ried M, Hacker U, Kurzeder C, Wendtner CM. Hallek M, et al. Internist (Berl). 2001 Oct;42(10):1306-8, 1311-3. doi: 10.1007/s001080170052. Internist (Berl). 2001. PMID: 11688149 Review. German. No abstract available.

9

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.

Nicklin SA, Buening H, Dishart KL, de Alwis M, Girod A, Hacker U, Thrasher AJ, Ali RR, Hallek M, Baker AH. Nicklin SA, et al. Among authors: hallek m. Mol Ther. 2001 Sep;4(3):174-81. doi: 10.1006/mthe.2001.0424. Mol Ther. 2001. PMID: 11545607 Free article.

10

A novel directed evolution method to enhance cell-type specificity of adeno-associated virus vectors.

Märsch S, Huber A, Hallek M, Büning H, Perabo L. Märsch S, et al. Among authors: hallek m. Comb Chem High Throughput Screen. 2010 Nov;13(9):807-12. doi: 10.2174/138620710792927385. Comb Chem High Throughput Screen. 2010. PMID: 20615200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

827 results

Search Page

Filters